Aspen Pharmacare Holdings Limited APNHY
10.04 USD +0.38 (+3.93%)
Nov 4, 2026, 11:49 AM EST
10.04 Day range 10.04
5.25 52-week range 10.05
- YTD
- +52.58%
- 1 year
- +82.21%
- Market cap
- 4.35B
- EPS (ttm)
- -0.12
- YTD return
- +52.58%
- 1-year return
- +82.21%
- Volume
- 100
- Avg volume
- 581
- Open
- 10.04
- Previous close
- 9.66
- Day's range
- 10.04 – 10.04
- 52-week range
- 5.25 – 10.05
2Y -0.44 (-4.20%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 3, 2026 | Dec 31, 2025 | — | 0.189 | — | — |
| Sep 3, 2025 | Jun 30, 2025 | — | -0.44005 | — | — |
| Mar 4, 2025 | Dec 31, 2024 | — | 0.3474 | — | — |
| Sep 2, 2024 | Jun 30, 2024 | 0.568 | 0.568 | 0.00 | 0.00% |
| Mar 4, 2024 | Dec 31, 2023 | — | 0.3264 | — | — |
News
Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year? 
Are Medical Stocks Lagging Aspen Pharmacare (APNHY) This Year? 
Aspen Pharmacare (OTCMKTS:APNHY) Shares Gap Down – Should You Sell? 
Is Aspen Pharmacare (APNHY) Stock Outpacing Its Medical Peers This Year? 
Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year? 
Aspen sees Mounjaro Africa sales above $124 million in 2027 
Aspen Pharmacare Holdings Limited (APNHY) Q4 2026 Earnings Call Transcript 
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript 
Aspen Pharmacare Holdings Limited (APNHY) Q2 2026 Earnings Call Transcript 
Aspen Pharmacare aims for Canada entry with Ozempic generic by third quarter
Your note
Sign in to keep a note on APNHY — it syncs with the Stock Master app.